AIMZ Investment Advisors LLC trimmed its stake in Proto Labs, Inc. (NYSE:PRLB – Free Report) by 2.0% during the second quarter, HoldingsChannel reports. The institutional investor owned 46,523 shares of the industrial products company’s stock after selling 950 shares during the period. AIMZ Investment Advisors LLC’s holdings in Proto Labs were worth $1,437,000 as of its most recent SEC filing.
A number of other hedge funds have also recently modified their holdings of the stock. Cornercap Investment Counsel Inc. purchased a new position in Proto Labs during the 2nd quarter worth $514,000. Jupiter Asset Management Ltd. grew its position in Proto Labs by 2.5% during the 2nd quarter. Jupiter Asset Management Ltd. now owns 150,704 shares of the industrial products company’s stock worth $4,655,000 after purchasing an additional 3,693 shares during the last quarter. American Century Companies Inc. grew its position in Proto Labs by 1.9% during the 2nd quarter. American Century Companies Inc. now owns 42,931 shares of the industrial products company’s stock worth $1,326,000 after purchasing an additional 812 shares during the last quarter. Quest Partners LLC grew its position in Proto Labs by 146.5% during the 2nd quarter. Quest Partners LLC now owns 30,403 shares of the industrial products company’s stock worth $939,000 after purchasing an additional 18,068 shares during the last quarter. Finally, Innealta Capital LLC purchased a new position in Proto Labs during the 2nd quarter worth $40,000. 84.54% of the stock is owned by hedge funds and other institutional investors.
Proto Labs Stock Performance
PRLB stock opened at $29.18 on Thursday. Proto Labs, Inc. has a one year low of $23.01 and a one year high of $41.87. The company has a fifty day moving average of $30.84 and a 200-day moving average of $32.04. The stock has a market capitalization of $738.72 million, a PE ratio of 37.90 and a beta of 1.32.
Wall Street Analyst Weigh In
Several research analysts have issued reports on the stock. Cantor Fitzgerald reissued an “overweight” rating and set a $44.00 price objective on shares of Proto Labs in a research report on Tuesday, July 30th. Needham & Company LLC restated a “hold” rating on shares of Proto Labs in a research note on Monday, August 5th. Benchmark restated a “buy” rating and issued a $45.00 target price on shares of Proto Labs in a research note on Wednesday, May 29th. Finally, StockNews.com cut shares of Proto Labs from a “strong-buy” rating to a “buy” rating in a research note on Monday, August 5th. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $41.00.
Read Our Latest Stock Analysis on PRLB
Insider Activity at Proto Labs
In related news, CEO Robert Bodor acquired 3,480 shares of Proto Labs stock in a transaction that occurred on Friday, September 6th. The stock was purchased at an average price of $28.68 per share, for a total transaction of $99,806.40. Following the completion of the purchase, the chief executive officer now directly owns 80,878 shares of the company’s stock, valued at $2,319,581.04. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 1.20% of the company’s stock.
Proto Labs Profile
Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.
Recommended Stories
- Five stocks we like better than Proto Labs
- What is a SEC Filing?
- Analysts Recommend These 3 Sector ETFs for Long-Term Growth
- Transportation Stocks Investing
- Can Roblox Really Grow to 1 Billion Active Daily Users?
- How Technical Indicators Can Help You Find Oversold StocksĀ
- Biotech Breakout: Stocks for Your Watchlist
Want to see what other hedge funds are holding PRLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Proto Labs, Inc. (NYSE:PRLB – Free Report).
Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.